These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27981439)

  • 1. Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.
    Jacobson TA; Edelman SV; Galipeau N; Shields AL; Mallya UG; Koren A; Davidson MH
    Patient; 2017 Jun; 10(3):321-334. PubMed ID: 27981439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Patient Perception of Statin Experience: A Qualitative Study.
    Vrablik M; Catapano AL; Wiklund O; Qian Y; Rane P; Grove A; Martin ML
    Adv Ther; 2019 Oct; 36(10):2723-2743. PubMed ID: 31482507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
    Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
    Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
    Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
    Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
    Stokes J; Evans CJ; Pompilus F; Shields AL; Summers KH
    Patient; 2013; 6(4):291-305. PubMed ID: 24062234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom).
    Brod M; Waldman LT; Smith A; Karpf D
    Patient; 2020 Apr; 13(2):151-162. PubMed ID: 31552607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
    Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
    J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Content Validity Testing of Patient-Reported Outcome Items for Children to Self-Assess Symptoms of the Common Cold.
    Halstead P; Arbuckle R; Marshall C; Zimmerman B; Bolton K; Gelotte C
    Patient; 2020 Apr; 13(2):235-250. PubMed ID: 31858430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.
    Sloesen B; Young A; Forde K; Hodson N; Bentley S; Walsh O; Naujoks C; O'Brien P; Sharma G
    J Patient Rep Outcomes; 2023 Jul; 7(1):64. PubMed ID: 37405617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis.
    Banderas B; Skup M; Shields AL; Mazar I; Ganguli A
    Curr Med Res Opin; 2017 Sep; 33(9):1643-1651. PubMed ID: 28574727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and content validity of a hemodialysis symptom patient-reported outcome measure.
    Flythe JE; Dorough A; Narendra JH; Wingard RL; Dalrymple LS; DeWalt DA
    Qual Life Res; 2019 Jan; 28(1):253-265. PubMed ID: 30229532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ).
    Becker B; Bracher M; Chauhan D; Rendas-Baum R; Lin X; Raymond K; O'Connor M; Kosinski M
    J Patient Rep Outcomes; 2021 Dec; 5(1):129. PubMed ID: 34894330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
    Lasch KE; Hassan M; Endicott J; Piault-Luis EC; Locklear J; Fitz-Randolph M; Pathak S; Hwang S; Jernigan K
    BMC Psychiatry; 2012 Apr; 12():34. PubMed ID: 22534028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
    Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Multiple Myeloma Symptom and Impact Questionnaire: A New Patient-Reported Outcome Instrument to Assess Symptom and Impacts in Patients With Multiple Myeloma.
    Gries KS; Fastenau J; Seo C; Potrata B; Iaconangelo C; Serrano D
    Value Health; 2021 Dec; 24(12):1807-1819. PubMed ID: 34838279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
    Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
    Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).
    Kimman ML; Rotteveel AH; Wijsenbeek M; Mostard R; Tak NC; van Jaarsveld X; Storm M; Wijnsma KL; Gelens M; van de Kar NCAJ; Wetzels J; Dirksen CD
    Patient; 2017 Oct; 10(5):629-642. PubMed ID: 28357591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The arthritic patients' perspective of measuring treatment efficacy: Patient Reported Experience Measures (PREMs) as a quality tool.
    El Miedany Y; El Gaafary M; Youssef S; Ahmed I; Palmer D
    Clin Exp Rheumatol; 2014; 32(4):547-52. PubMed ID: 24984075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.